FDA-Inspected Site

Summit Biosciences Inc.

6 FDA inspections are on record for Summit Biosciences Inc. in Lexington, United States.

483· Form 483 issued

Lexington, United States · Last updated July 10, 2026

Overview

  • 6 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2025-02-21.

At a glance

Inspections

6

Form 483s

1

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
18 Feb 2025 – 21 Feb 2025Human Drugs483View 483 →
11 Sep 2023 – 14 Sep 2023Medical Devices & Rad HealthClean
30 Jan 2020 – 4 Feb 2020Human DrugsClean
19 Jun 2017 – 23 Jun 2017Human DrugsClean
9 Jun 2015 – 18 Jun 2015Human DrugsClean
24 Feb 2014 – 28 Feb 2014Medical Devices & Rad HealthClean

Observations on record

Form 483 observations cited at this site, most recent first.

21 Feb 2025
21 CFR 211.110(a)

Written in-process control procedures

Cited by Ucheabuchi C Chudi-Nwankwor

21 Feb 2025
FDCA 582(b)(4)

Systems in place to comply with verification requirements

Cited by Ucheabuchi C Chudi-Nwankwor

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
FDCA 582(b)(4)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Summit Biosciences Inc.'s 1 Form 483

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat